NEURAPTIVE
Live / Registered — Registered (as of 18 Jan 2022)
What this means for you
Registered since 18 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87749824
- Registration number
- 6622802
- Mark type
- Stylized text
- Filed
- 10 Jan 2018
- Published for opposition
- 18 Dec 2018
- Registered
- 18 Jan 2022
- Attorney of record
- Ian W. Gillies
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for use on the peripheral or central nervous system for the treatment of damaged or severed nerves; surgical implants comprised of biological material derived from human or animal tissue, used to protect or repair tissue of the peripheral or central nervous system
- Class 010 — Medical apparatus: medical device for preparing tissue of the peripheral or central nervous system for surgery; surgical implants comprised of synthetic artificial material, used to protect or repair tissue of the peripheral or central nervous system
Owner
- Neuraptive Therapeutics, Inc., Louisville, CO, US
- Neuraptive Therapeutics, Inc., Louisville, CO, US
- Neuraptive Therapeutics, Inc., Lafayette, CO, US
Prosecution history
- 18 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 14 Dec 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Dec 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Nov 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Feb 2021 — USE AMENDMENT FILED
- 10 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2021 — SOU EXTENSION 4 GRANTED
- 02 Feb 2021 — SOU EXTENSION 4 FILED
- 08 Mar 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Feb 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Feb 2021 — SOU TEAS EXTENSION RECEIVED
- 02 Feb 2021 — TEAS STATEMENT OF USE RECEIVED
- 06 Aug 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Aug 2020 — SOU EXTENSION 3 GRANTED
- 04 Aug 2020 — SOU EXTENSION 3 FILED